« FDA Approvals - Bayer/Onyx Pharmaceuticals: Nexavar approval in liver cancer will boost sales | Main | More than $300,000 of Drugs and Dietary Supplements Seized At »

ISI Announces Expansion Of Mid-Market Life Science Compliance Solutions At


ISI Announces Expansion Of Mid-Market Life Science Compliance Solutions At DIA eCTD Conference (PharmaceuticalOnline)
Image Solutions, Inc. (ISI), a leading provider of software and services to streamline the drug development and regulatory approval process, recently unveiled its strategy to deliver packaged regulatory compliance solutions and services to emerging and mid-market life sciences organizations at the 6 th Annual Electronic Submissions Conference hosted by the Drug Information Association (DIA).

Health Canada Licenses QIAGEN's New Molecular Test For Hepatitis B (Medical News Today)
QIAGEN announced that its newly released hepatitis B virus (HBV) assay kit is in compliance with Health Canada's medical device requirements. The artus HBV LC PCR Kit, which monitors the viral load of HBV infected patients, is now available to doctors in Canada to help them determine the success of a treatment. [click link for full article]
 

©2006 FDA-News.com. All rights reserved.